Rockbridge Investment Management, Lcc Vertex Pharmaceuticals Inc Transaction History

Rockbridge Investment Management, Lcc

  • $772 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 28, 2024
SELL
$273.83 - $305.53 $13,691 - $15,276
-50 Closed
0 $0
Q1 2022

May 28, 2024
BUY
$221.42 - $260.97 $11,071 - $13,048
50 New
50 $13,000
Q1 2021

May 20, 2021
BUY
$207.02 - $241.31 $4,140 - $4,826
20 Added 66.67%
50 $11,000
Q2 2020

Aug 20, 2020
BUY
$225.48 - $295.8 $6,764 - $8,874
30 New
30 $9,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Rockbridge Investment Management, Lcc Portfolio

Follow Rockbridge Investment Management, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email